Mimedx (MDXG) Enterprise Value (2010 - 2026)

Mimedx has disclosed Enterprise Value across 17 years of filings, most recently posting -$159.8 million for Q1 2026.

• Enterprise Value for Q1 2026 came in at -$159.8 million, down 50.12% year-over-year; the trailing twelve-month figure through Mar 2026 was -$159.8 million (down 50.12% YoY), and the FY2025 annual result was -$166.1 million, down 59.1% from the prior year.
• Enterprise Value came in at -$159.8 million for Q1 2026 at Mimedx, up from -$166.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$48.5 million in Q1 2024 to a low of -$166.1 million in Q4 2025.
• The 5-year median for Enterprise Value is -$78.8 million (2022), against an average of -$94.0 million.
• Across the five-year window, Enterprise Value climbed 24.27% in 2022 and sank 119.5% in 2025, its largest moves.
• Mimedx's Enterprise Value stood at -$66.0 million in 2022, then retreated by 24.34% to -$82.0 million in 2023, then declined by 27.34% to -$104.4 million in 2024, then tumbled by 59.1% to -$166.1 million in 2025, then advanced by 3.82% to -$159.8 million in 2026.
• The last three Enterprise Value figures came in at -$159.8 million (Q1 2026), -$166.1 million (Q4 2025), and -$142.1 million (Q3 2025), per Business Quant data.